U.S. stocks decline as data bolster concern on stimulus: Bloomberg

YEREVAN, June 1. /ARKA/. U.S. stocks fell, paring the seventh monthly gain for the Standard & Poor’s 500 Index, as better-than-forecast data on business activity and consumer confidence bolstered concern the Federal Reserve will scale back stimulus.

All 10 groups in the S&P 500 retreated, as health-care, energy and consumer staple stocks led declines. Pall Corp. (PLL) retreated 5.1 percent after lowering an earnings forecast. American International Group Inc. slid 3.8 percent after saying it hasn’t received a deposit in the sale of its plane-leasing unit. Monsanto Co. fell 4.1 percent after an unapproved, genetically modified strain of wheat was discovered growing.

The S&P 500 fell 1.4 percent to 1,630.74 in New York after rising as much as 0.3 percent earlier. The Dow Jones Industrial Average lost 208.96 points, or 1.4 percent, to 15,115.57 today. More than 7.5 billion shares traded hands on U.S. exchanges today, 20 percent higher than the three-month average.

“May will be the seventh month in a row where the S&P 500 has traded higher, and the markets are maybe looking for a reason to pause or consolidate,” Jim Russell, a senior equity strategist in Cincinnati at U.S. Bank Wealth Management, which oversees about $110 billion in assets, said by telephone. “We wouldn’t be surprised to see the market trade sideways to down in the weeks ahead on, call it, slow summer months, questions around Fed tightening and perhaps sluggish earnings growth in the second quarter.”

Changes by MSCI Inc. to its global and U.S. equity indexes were implemented at the close of trading today, a process that can lead to swings in affected stocks. The additions and deletions of stocks, known as rebalancing, to gauges such as the MSCI All-Country World Index and the MSCI World Index of developed-market equities were announced on May 15. –0–

spot_img

POPULAR

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Central Bank of Armenia warns of fraudulent schemes involving bank accounts

YEREVAN, August 17. /ARKA/. Recently, there has been an increase in cases of criminals luring citizens into suspicious financial transactions using their bank accounts or cryptocurrency accounts, as well as e-wallets or cards to transfer criminally obtained funds, in order to conceal their true origin and beneficiaries, according to a statement from the Central Bank of Armenia's press service.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

Acba Bank has issued over 1 million cards, solidifying its leadership in Armenia

YEREVAN, August 17. /ARKA/. For more than five years, Acba Bank has held the top spot in the Armenian card market. As of May 2026, the total number of cards issued by the bank surpassed 1 million, as reported by the bank's press service.

LATEST NEWS

spot_imgspot_imgspot_img